UK MedTech: Dual Mandate – Patient Safety & Data Privacy After the 2025 PMS Regulations

The Core Challenge: Post-Market Surveillance (PMS) vs. Privacy

The regulatory landscape for medical devices in Great Britain has just been fundamentally reshaped. Effective June 16, 2025, the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 introduce a mandate for manufacturers to intensify their monitoring efforts once devices are on the market. The goal is clear: faster detection of safety issues and better containment of risk.

However, this commitment to patient safety creates a complex challenge for data privacy and compliance teams. Increased monitoring means more data collection, heightened retention risks, and faster reporting requirements, all of which must be reconciled with the UK's stringent data protection laws (UK GDPR).

What We Cover in This Episode:

Your hosts Annie Garcia and Rob Healey Formiti Data International break down this critical compliance overlap, detailing how MedTech manufacturers must adapt to the new dual mandate:

• The New Regulatory Baseline: We explain the shift from guidance to mandatory law, focusing on the new requirement for a PMS Plan for every device placed on the GB market.
• Data Collection Intensifies: The new rules mandate manufacturers to actively collect a wider range of data, including patient feedback and data on "similar devices" (competitors' products). We discuss the privacy implications of this enhanced data scope.
• The Unique Data Risk of Wearables: Many modern devices (wearables, apps, continuous monitors) collect sensitive, identifiable personal data in real-time. We analyze how the new PMS obligations for trend reporting and serious incident notifications must be flawlessly integrated with UK GDPR's data minimization and breach notification rules.
• The Reporting Time Crunch: The regulations introduce shorter reporting timelines for serious incidents to the MHRA. We discuss the operational necessity of having a system that can immediately isolate, verify, and report data while maintaining compliance integrity.
• Compliance Action Plan: We conclude with a clear checklist for manufacturers on how to update their Technical Documentation and Privacy Notices to reflect the new, intensified PMS activities without violating patient data rights.

This episode is essential for any regulatory, legal, or compliance professional dealing with medical devices in the Great Britain market.